Virtual Medicinal Product (VMP) - Neostigmine 2.5mg/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Neostigmine 2.5mg/1ml solution for injection ampoules Start Date 21-06-2004 End Date
Previous Name Previous Name Neostigmine 2.5mg/ml injection 1ml ampoules Start Date 19-06-2003 End Date 20-06-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous, Subcutaneous, Intramuscular
Form
Solution for injection
Ontology Form/Route
solutioninjection.subcutaneous, solutioninjection.intramuscular, solutioninjection.intravenous
Name Basis
BAN - British Approved Name

Codes

ATC Code
N07AA01
BNF Start Date End Date
Current BNF 10020100 Start Date 04-04-2022 End Date
Previous BNF 10020100 Start Date 21-02-2005 End Date 03-04-2022
Previous BNF 15010600 Start Date 21-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36030811000001104 29-10-2018
330099008 19-06-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Neostigmine metilsulfate Based on Ingredient Substance 2.5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule